Valuation : Circio Holding ASA

Market Cap 3.55B 382M 329M 309M 283M 529M 36.08B 530M 3.66B 1.42B 18.51B 1.44B 1.4B 59.64B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 3.56B 382M 329M 310M 283M 529M 36.11B 531M 3.66B 1.42B 18.52B 1.44B 1.4B 59.68B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -
1 day+6.07%
1 week-1.97%
Current month+0.15%
1 month+48.74%
3 months+53.68%
6 months+287.43%
Current year+1,011.68%
1 week 11.16
Extreme 11.16
15.7
1 month 8.34
Extreme 8.34
15.7
Current year 0.98
Extreme 0.978
15.7
1 year 0.58
Extreme 0.580999
15.7
3 years 0.48
Extreme 0.48
15.7
5 years 0.48
Extreme 0.48
236.7
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 19/10/2021
Director of Finance/CFO 58 06/03/2022
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Director/Board Member 79 30/06/2015
Director/Board Member 66 13/09/2015
Chairman 64 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/11/21 Exercice

Chief Executive Officer

120,000 0.1386%
19/05/21 Buy

Director

21,299 0.0246%
03/12/20 Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
+6.07%-1.97%+2,035.32%-19.07% 382M
-1.79%-2.27%+43.23%+99.78% 67.98B
-2.06%-0.18%+39.67%+85.24% 64.94B
-0.31%+6.54%-12.96%+377.83% 27.58B
+0.86%+1.65%-7.74%-13.58% 26.06B
-3.00%-2.90%+33.13%+14.91% 25.74B
-1.46%+0.42%+23.61%-16.76% 20.09B
-2.96%-15.21%+216.20%+375.70% 17.16B
-1.49%-4.88%-6.60%+559.57% 14.92B
-0.20%+8.37%+55.78%+165.57% 14.62B
Average -0.63%+0.03%+241.96%+162.92% 27.95B
Weighted average by Cap. -1.51%+0.17%+41.10%+141.83%

Financials

2024 2025
Net sales - -
Net income 57.52M 6.19M 5.32M 5.01M 4.58M 8.56M 584M 8.58M 59.18M 22.97M 300M 23.23M 22.72M 965M -45.91M -4.94M -4.25M -4M -3.65M -6.83M -466M -6.85M -47.23M -18.33M -239M -18.54M -18.13M -770M
Net Debt -972K -105K -89.95K -84.63K -77.31K -145K -9.87M -145K -1M -388K -5.06M -393K -384K -16.31M 2.24M 241K 208K 195K 179K 334K 22.8M 335K 2.31M 896K 11.7M 907K 887K 37.68M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
11
Date Price Change Volume
04/09/26 NOK 12.94 +6.07% 14,153,698
03/09/26 NOK 12.20 +0.49% 13,089,208
02/09/26 NOK 12.14 0.00% 21,106,493
01/09/26 NOK 12.14 -6.04% 41,859,776
31/08/26 NOK 12.92 -2.12% 8,967,198

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CRNA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!